95 reports of this reaction
1.9% of all LEVONORGESTREL AND ETHINYL ESTRADIOL reports
#11 most reported adverse reaction
OFF LABEL USE is the #11 most commonly reported adverse reaction for LEVONORGESTREL AND ETHINYL ESTRADIOL, manufactured by Teva Pharmaceuticals USA, Inc.. There are 95 FDA adverse event reports linking LEVONORGESTREL AND ETHINYL ESTRADIOL to OFF LABEL USE. This represents approximately 1.9% of all 4,908 adverse event reports for this drug.
Patients taking LEVONORGESTREL AND ETHINYL ESTRADIOL who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OFF LABEL USE is a less commonly reported adverse event for LEVONORGESTREL AND ETHINYL ESTRADIOL, but still significant enough to appear in the safety profile.
In addition to off label use, the following adverse reactions have been reported for LEVONORGESTREL AND ETHINYL ESTRADIOL:
The following drugs have also been linked to off label use in FDA adverse event reports:
OFF LABEL USE has been reported as an adverse event in 95 FDA reports for LEVONORGESTREL AND ETHINYL ESTRADIOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
OFF LABEL USE accounts for approximately 1.9% of all adverse event reports for LEVONORGESTREL AND ETHINYL ESTRADIOL, making it a notable side effect.
If you experience off label use while taking LEVONORGESTREL AND ETHINYL ESTRADIOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.